{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:51:20Z","timestamp":1779223880221,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01034-z","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T18:22:40Z","timestamp":1679854960000},"page":"2695-2703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7943-9176","authenticated-orcid":false,"given":"Tetsuhiro","family":"Kasamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaya","family":"Awata-Shiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanami","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yokohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"1034_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"F di DaddaFagagna","year":"2008","unstructured":"di DaddaFagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1034_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature03098","volume":"432","author":"SW Lowe","year":"2004","unstructured":"Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432:307\u201315.","journal-title":"Nature"},{"key":"1034_CR3","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1242\/jcs.113.20.3613","volume":"113","author":"DJ Kurz","year":"2000","unstructured":"Kurz DJ, Decary S, Hong Y, Erusalimsky JD. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci. 2000;113:3613\u201322.","journal-title":"J Cell Sci"},{"key":"1034_CR4","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1034_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chembiol.2014.11.013","volume":"22","author":"M Srivastava","year":"2015","unstructured":"Srivastava M, Raghavan SC. DNA double-strand break repair inhibitors as cancer therapeutics. Chem Biol. 2015;22:17\u201329.","journal-title":"Chem Biol"},{"key":"1034_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ncb1004","volume":"5","author":"A Celeste","year":"2003","unstructured":"Celeste A, Fernandez-Capetillo O, Kruhlak MJ, et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol. 2003;5:675\u20139.","journal-title":"Nat Cell Biol"},{"key":"1034_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"1034_CR8","doi-asserted-by":"publisher","first-page":"103409","DOI":"10.1016\/j.ebiom.2021.103409","volume":"68","author":"J Zhang","year":"2021","unstructured":"Zhang J, He T, Xue L, Guo H. Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine. 2021;68:103409.","journal-title":"EBioMedicine"},{"key":"1034_CR9","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","volume":"101","author":"JM Brenchley","year":"2003","unstructured":"Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711\u201320.","journal-title":"Blood"},{"key":"1034_CR10","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","volume":"113","author":"SM Henson","year":"2009","unstructured":"Henson SM, Franzese O, Macaulay R, et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood. 2009;113:6619\u201328.","journal-title":"Blood"},{"key":"1034_CR11","doi-asserted-by":"publisher","first-page":"e000639","DOI":"10.1136\/jitc-2020-000639","volume":"8","author":"B Huang","year":"2020","unstructured":"Huang B, Liu R, Wang P, et al. CD8+CD57+ T cells exhibit distinct features in human non-small cell lung cancer. J Immunother Cancer. 2020;8:e000639.","journal-title":"J Immunother Cancer"},{"key":"1034_CR12","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fimmu.2018.01651","volume":"9","author":"L Trintinaglia","year":"2018","unstructured":"Trintinaglia L, Bandinelli LP, Grassi-Oliveira R, et al. Features of immunosenescence in women newly diagnosed with breast cancer. Front Immunol. 2018;9:1651.","journal-title":"Front Immunol"},{"key":"1034_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s10147-008-0789-8","volume":"13","author":"J Akagi","year":"2008","unstructured":"Akagi J, Baba H. Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer. Int J Clin Oncol. 2008;13:528\u201335.","journal-title":"Int J Clin Oncol"},{"key":"1034_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.21147\/j.issn.1000-9604.2017.05.11","volume":"29","author":"J Tan","year":"2017","unstructured":"Tan J, Chen S, Lu Y, et al. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia. Chin J Cancer Res. 2017;29:463\u201370.","journal-title":"Chin J Cancer Res"},{"key":"1034_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00262-015-1773-6","volume":"65","author":"D Saavedra","year":"2016","unstructured":"Saavedra D, Garc\u00eda B, Lorenzo-Luaces P, et al. Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients. Cancer Immunol Immunother. 2016;65:37\u201345.","journal-title":"Cancer Immunol Immunother"},{"key":"1034_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1186\/s12885-015-2013-3","volume":"15","author":"OO Onyema","year":"2015","unstructured":"Onyema OO, Decoster L, Njemini R, et al. Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study. BMC Cancer. 2015;15:1016.","journal-title":"BMC Cancer"},{"key":"1034_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s40425-019-0825-4","volume":"7","author":"E Bruni","year":"2019","unstructured":"Bruni E, Cazzetta V, Donadon M, et al. Chemotherapy accelerates immune-senescence and functional impairments of V\u03b42pos T cells in elderly patients affected by liver metastatic colorectal cancer. J Immunother Cancer. 2019;7:347.","journal-title":"J Immunother Cancer"},{"key":"1034_CR18","doi-asserted-by":"publisher","first-page":"15807","DOI":"10.1073\/pnas.0908805106","volume":"106","author":"K Shimatani","year":"2009","unstructured":"Shimatani K, Nakashima Y, Hattori M, Hamazaki Y, Minato N. PD-1+ memory phenotype CD4+ T cells expressing C\/EBPalpha underlie T cell immunodepression in senescence and leukemia. Proc Natl Acad Sci USA. 2009;106:15807\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1034_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drup.2012.01.002","volume":"15","author":"RR Gordon","year":"2012","unstructured":"Gordon RR, Nelson PS. Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat. 2012;15:123\u201331.","journal-title":"Drug Resist Updat"},{"key":"1034_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.mad.2005.03.006","volume":"126","author":"FJ Plunkett","year":"2005","unstructured":"Plunkett FJ, Franzese O, Belaramani LL, et al. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev. 2005;126:855\u201365.","journal-title":"Mech Ageing Dev"},{"key":"1034_CR21","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1182\/blood-2012-03-416040","volume":"120","author":"J Ye","year":"2012","unstructured":"Ye J, Huang X, Hsueh EC, et al. Human regulatory T cells induce T-lymphocyte senescence. Blood. 2012;120:2021\u201331.","journal-title":"Blood"},{"key":"1034_CR22","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3390\/cancers12102828","volume":"12","author":"W Liu","year":"2020","unstructured":"Liu W, Stachura P, Xu HC, Bhatia S, Borkhardt A, Lang PA, Pandyra AA. Senescent tumor CD8+ T cells: mechanisms of induction and challenges to immunotherapy. Cancers (Basel). 2020;12:2828.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1034_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jhep.2012.12.009","volume":"58","author":"M Hoare","year":"2013","unstructured":"Hoare M, Shankar A, Shah M, et al. \u03b3-H2AX+CD8+ T lymphocytes cannot respond to IFN-\u03b1, IL-2 or IL-6 in chronic hepatitis C virus infection. J Hepatol. 2013;58(5):868\u201374.","journal-title":"J Hepatol"},{"key":"1034_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41467-017-02689-5","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Mo W, Ye J, et al. Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition. Nat Commun. 2018;9:249.","journal-title":"Nat Commun"},{"key":"1034_CR25","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.4049\/jimmunol.1500319","volume":"194","author":"S Tahir","year":"2015","unstructured":"Tahir S, Fukushima Y, Sakamoto K, et al. A CD153+CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production. J Immunol. 2015;194:5725\u201335.","journal-title":"J Immunol"},{"issue":"2","key":"1034_CR26","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1111\/acel.13067","volume":"19","author":"LA Callender","year":"2020","unstructured":"Callender LA, Carroll EC, Bober EA, Akbar AN, Solito E, Henson SM. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19(2):e13067.","journal-title":"Aging Cell"},{"key":"1034_CR27","unstructured":"."},{"key":"1034_CR28","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1172\/JCI70355","volume":"123","author":"AM Mondal","year":"2013","unstructured":"Mondal AM, Horikawa I, Pine SR, et al. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J Clin Invest. 2013;123:5247\u201357.","journal-title":"J Clin Invest"},{"key":"1034_CR29","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1172\/JCI75051","volume":"124","author":"SM Henson","year":"2014","unstructured":"Henson SM, Lanna A, Riddell NE, et al. signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells. J Clin Invest. 2014;124:4004\u201316.","journal-title":"J Clin Invest"},{"key":"1034_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41232-018-0082-9","volume":"38","author":"Y Fukushima","year":"2018","unstructured":"Fukushima Y, Minato N, Hattori M. The impact of senescence-associated T cells on immunosenescence and age-related disorders. Inflamm Regen. 2018;38:24.","journal-title":"Inflamm Regen."},{"key":"1034_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4161\/onci.20823","volume":"1","author":"C Haymaker","year":"2012","unstructured":"Haymaker C, Wu R, Bernatchez C, Radvanyi L. PD-1 and BTLA and CD8(+) T-cell \u201cexhaustion\u201d in cancer: \u201cExercising\u201d an alternative viewpoint. Oncoimmunology. 2012;1:735\u20138.","journal-title":"Oncoimmunology"},{"key":"1034_CR32","doi-asserted-by":"publisher","first-page":"698565","DOI":"10.3389\/fimmu.2021.698565","volume":"12","author":"V Janelle","year":"2021","unstructured":"Janelle V, Neault M, Lebel M\u00c8, et al. p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells. Front Immunol. 2021;12:698565.","journal-title":"Front Immunol"},{"key":"1034_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3960","volume":"15","author":"NE Sharpless","year":"2015","unstructured":"Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015;15:397\u2013408.","journal-title":"Nat Rev Cancer"},{"key":"1034_CR34","doi-asserted-by":"publisher","unstructured":"Muroyama Y, Manne S, Wellhausen N, et al. Induction of a CD8 T cell intrinsic DNA damage and repair response is associated with clinical response to PD-1 blockade in uterine cancer. bioRxiv. doi: https:\/\/doi.org\/10.1101\/2022.04.16.488552.","DOI":"10.1101\/2022.04.16.488552"},{"key":"1034_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/bloodadvances.2017011254","volume":"2","author":"CT Petersen","year":"2018","unstructured":"Petersen CT, Hassan M, Morris AB, et al. Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3K\u03b4 inhibitors and VIP antagonists. Blood Adv. 2018;2:210\u201323.","journal-title":"Blood Adv"},{"key":"1034_CR36","doi-asserted-by":"publisher","first-page":"568056","DOI":"10.3389\/fonc.2020.568056","volume":"10","author":"T Mika","year":"2020","unstructured":"Mika T, Ladigan-Badura S, Maghnouj A, et al. Altered T-lymphocyte biology following high-dose melphalan and autologous stem cell transplantation with implications for adoptive T-cell therapy. Front Oncol. 2020;10:568056.","journal-title":"Front Oncol"},{"key":"1034_CR37","doi-asserted-by":"publisher","first-page":"604591","DOI":"10.3389\/fimmu.2020.604591","volume":"11","author":"IJ Rodriguez","year":"2021","unstructured":"Rodriguez IJ, Lalinde Ruiz N, Llano Le\u00f3n M, et al. Immunosenescence study of T cells: a systematic review. Front Immunol. 2021;11:604591.","journal-title":"Front Immunol"},{"key":"1034_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF00254244","volume":"22","author":"PA Reece","year":"1988","unstructured":"Reece PA, Hill HS, Green RM, et al. Renal clearance and protein binding of melphalan in patients with cancer. Cancer Chemother Pharmacol. 1988;22:348\u201352.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1034_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1200\/JCO.1988.6.3.517","volume":"6","author":"K Mross","year":"1988","unstructured":"Mross K, Maessen P, van der Vijgh WJ, Gall H, Boven E, Pinedo HM. Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. J Clin Oncol. 1988;6:517\u201326.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01034-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01034-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01034-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:17:34Z","timestamp":1696079854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01034-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01034-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2058604\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Gunma University Hospital (Approval # HS2019-247) and with the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}